Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands
BACKGROUND: Use of the direct oral anticoagulant rivaroxaban has strongly increased in Europe since its market approval for non-valvular atrial fibrillation in 2011. Patients characteristics of rivaroxaban initiators may have changed over time but this has not been investigated so far. OBJECTIVE: We aimed to describe time trends of patient baseline characteristics among new rivaroxaban users with non-valvular atrial fibrillation from 2011 to 2016/17 in two European countries. METHODS: We used data from Germany (German Pharmacoepidemiological Research Database) and the Netherlands (PHARMO Datab... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Zeitschriftenartikel |
Erscheinungsdatum: | 2023 |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27624553 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://repository.publisso.de/resource/frl:6452775 |